DOPAMINE HYDROCHLORIDE

Post-LOE

dopamine hydrochloride

AbbVie

ANDAINJECTIONINJECTABLE

Approved

Feb 1987

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

DOPAMINE HYDROCHLORIDE (dopamine hydrochloride) by AbbVie is clinical pharmacology dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (dopa). Approved for hemodynamic status in patients in shock. First approved in 1987.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal…

Worked on DOPAMINE HYDROCHLORIDE at AbbVie? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

DOPAMINE HYDROCHLORIDE

Mechanism of Action

Indications (1)